{"DataElement":{"publicId":"3861385","version":"2","preferredName":"Best Overall Lesion Response Type","preferredDefinition":"Text to represent the best overall disease response recorded from the start of the study treatment until the end of treatment taking into account any requirements for confirmation.","longName":"BST_OVERALL_LES_RESP_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3861381","version":"1","preferredName":"Best Overall Lesion Response","preferredDefinition":"Having the most positive qualities._Including everything._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"3861379v1.0:2193203v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3861379","version":"1","preferredName":"Best Overall Lesion","preferredDefinition":"Having the most positive qualities.:Including everything.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","longName":"C25432:C25605:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E48AB905-C87B-6390-E040-BB89AD43301A","latestVersionIndicator":"Yes","beginDate":"2013-08-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-22","modifiedBy":"ONEDATA","dateModified":"2013-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193203","version":"1","preferredName":"Response","preferredDefinition":"Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"C25755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EACFDBFA-EFCE-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E48AB905-C889-6390-E040-BB89AD43301A","latestVersionIndicator":"Yes","beginDate":"2013-08-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-22","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"8/31/17 tt transferred context, added registration status and CSI per Round 5 finalization task. 6/3/14 CDE/DEC released for DCP reuse. jc  8/22/13 created for RECIST CRF. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3859427","version":"2","preferredName":"RECIST Best Overall Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)._Having the most positive qualities._Including everything._Something distinguishable as an identifiable class based on common qualities.","longName":"3859427v2.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"581054CF-F227-4524-E053-F662850A3327","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"NE","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3855538","version":"1","preferredName":"Unevaluable","longName":"3855538","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F3FD8B-328D-C859-E040-BB89AD43580F","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"581054CF-F231-4524-E053-F662850A3327","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"3951936","version":"1","preferredName":"Complete Remission","longName":"3951936v1.00","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5DA-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"581054CF-F23B-4524-E053-F662850A3327","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"SD duration met otherwise NE","valueDescription":"Stable Disease Duration Met If Not Unevaluable ","ValueMeaning":{"publicId":"5946445","version":"1","preferredName":"Stable Disease Duration Met If Not Unevaluable ","longName":"5946445","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.: The period of time during which something continues.: Satisfy the requirements or expectations of.: A modifier term indicating a condition to follow.: An operation in which a term denies or inverts the meaning of another term or construction.: Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"If","conceptCode":"C64955","definition":"A modifier term indicating a condition to follow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58111BAF-E68C-119F-E053-F662850A7110","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58111BAF-E6A5-119F-E053-F662850A7110","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Remission","ValueMeaning":{"publicId":"3951935","version":"1","preferredName":"Partial Remission","longName":"3951935","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5B7-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58111BAF-E6AF-119F-E053-F662850A7110","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"SD duration met otherwise PD","valueDescription":"Stable Disease Duration Met If Not Progressive Disease","ValueMeaning":{"publicId":"5946440","version":"1","preferredName":"Stable Disease Duration Met If Not Progressive Disease","longName":"5946440","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.: The period of time during which something continues.: Satisfy the requirements or expectations of.: A modifier term indicating a condition to follow.: An operation in which a term denies or inverts the meaning of another term or construction.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"If","conceptCode":"C64955","definition":"A modifier term indicating a condition to follow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"581054CF-F204-4524-E053-F662850A3327","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5810FD7E-C480-3C25-E053-F662850A8538","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"3859302","version":"1","preferredName":"Stable Disease","longName":"3859302","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E461EC27-2518-B912-E040-BB89AD43049F","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SOKKERL","dateModified":"2023-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580FAFB9-8711-0F5F-E053-F662850ADA00","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3859426","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Best Overall Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com):Having the most positive qualities.:Including everything.:Something distinguishable as an identifiable class based on common qualities.","longName":"C49164:C25432:C25605:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E463912B-7E25-0F0A-E040-BB89AD431590","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"ONEDATA","dateModified":"2013-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"580FAFB9-86D1-0F5F-E053-F662850ADA00","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"8/30/17 tt VD versioned for changes to max length and PVs per RECIST 1.1; transferred Context, added CSI and reg status per Round 5 finalization task.   6/3/14 added Non-CR/Non-PD value per CCR Round 5 community review comment; upd max length and release VD and CDE for DCP reuse. jc  8/20/13 created for RECIST CRF module based on RECISTv1.1 value definitions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"11518160","version":"1","longName":"CTDC (Clinical Trial Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"13484614","version":"1","longName":"ECOG-ACRIN DD","context":"CRDC"},{"publicId":"13484613","version":"1","longName":"MATCHBox","context":"CRDC"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"},{"publicId":"3308730","version":"1","longName":"MediData Rave Use","context":"CCR"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3794651","version":"1","longName":"RECIST CRF","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"}]},{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]},{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"5506169","version":"1","longName":"Lung-Vanderbilt","context":"MCL"},{"publicId":"5506172","version":"1","longName":"Clinical","context":"MCL"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006643","version":"1","longName":"RECISTv1.1","context":"NCI Standards"}]}],"AlternateNames":[{"name":"BstOvrAllLesRespTyp","type":"COG GDE Short Name","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"best_conf_resp","type":"CTDC Alt Name","context":"CRDC"},{"name":"best_overall_reponse","type":"CTDC Alt Name","context":"CRDC"},{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Best overall response","type":"Preferred Question Text","description":"Best overall response","url":null,"context":"NCI Standards"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Best overall response:","url":null,"context":"COG"},{"name":"RECIST","type":"Alternate Question Text","description":"Best overall response","url":null,"context":"NCI Standards"},{"name":"MCL-Lung-1","type":"Alternate Question Text","description":"Date of best response (RECIST criteria (CR, PR, PD, SD)","url":null,"context":"MCL"},{"name":"Overall response:","type":"Alternate Question Text","description":"Overall response:","url":null,"context":"COG"}],"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5811DAA7-224E-51B9-E053-F662850A3BD3","latestVersionIndicator":"Yes","beginDate":"2013-08-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"8/31/17 tt CDE versioned for change to VD and short name; transferred Context, changed reg status and released per Round 5 finalization task. 5/28/16 jk moved from EDRN to MCL context CSI.  12/12/14 jc added Exceptional Responder CSI. 6/3/14 added Non-CR/Non-PD value per CCR Round 5 community review comment; upd max length and released CDE/DEC/VD for DCP reuse. jc  11/20/13 changed origin to RECISTv1.1. jc  8/22/13 created for RECIST CRF module based on section 4.4.3 and Table 3 of RECISTv1.1 Guidelines.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}